机构名称：
¥ 1.0
Carthera signs strategic collaboration with Accord Healthcare Partnership will further development, manufacturing and commercialization of carboplatin to be used with SonoCloud system for treatment of recurrent glioblastoma Paris, France, November 6, 2023 – Carthera, a spin-off from Sorbonne University founded by Pr Alexandre Carpentier, and developer of SonoCloud ® , an innovative ultrasound-based medical device to treat a多种大脑疾病，今天宣布与领先的制药公司Accord Healthcare Limited签署战略合作，以供应卡铂。该协议的财务条款尚未披露。该合作伙伴关系涵盖了未来几年通过对卡瑟拉的契约医疗保健的开发和供应。卡铂是Carthera的Sonocloud解决方案的核心组成部分，用于治疗复发性胶质母细胞瘤（RGBM）。通过本协议，Carthera加强了其声云系统的概况，促进了监管机构的批准过程，并确保了卡铂的供应以及随后的商业化。
Carthera与Accord Healthcare的战略合作
主要关键词
相关文件推荐
